228 related articles for article (PubMed ID: 2437988)
1. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.
Kromer W; Baron E; Beinborn M; Boer R; Eltze M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):165-70. PubMed ID: 1692974
[TBL] [Abstract][Full Text] [Related]
3. The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle.
Elnatan A; Mitchelson F
Biochem Pharmacol; 1993 Sep; 46(6):993-1003. PubMed ID: 7692853
[TBL] [Abstract][Full Text] [Related]
4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
5. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.
Hishinuma S; Hongo I; Matsumoto Y; Narita F; Kurokawa M
Br J Pharmacol; 1997 Nov; 122(6):985-92. PubMed ID: 9401759
[TBL] [Abstract][Full Text] [Related]
7. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
10. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
Richards MH
Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
[TBL] [Abstract][Full Text] [Related]
11. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart.
Birdsall NJ; Burgen AS; Hulme EC; Stockton JM; Zigmond MJ
Br J Pharmacol; 1983 Feb; 78(2):257-9. PubMed ID: 6187403
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic action of disopyramide in intestinal smooth muscle of the guinea pig: inhibition of muscarinic receptors (M1 and M2).
Ishida Y; Mizukami M; Taniguchi T; Satake N; Fujiwara M; Shibata S
Jpn J Pharmacol; 1990 Feb; 52(2):363-70. PubMed ID: 1690310
[TBL] [Abstract][Full Text] [Related]
13. The interaction of hexamethonium with muscarinic receptor subtypes in vitro.
Eglen RM; Michel AD; Cornett CM; Kunysz EA; Whiting RL
Br J Pharmacol; 1989 Oct; 98(2):499-506. PubMed ID: 2819331
[TBL] [Abstract][Full Text] [Related]
14. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Jul; 35(15):2787-98. PubMed ID: 1379640
[TBL] [Abstract][Full Text] [Related]
15. Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Beleslin DB; Nedelkovski V
Neuropharmacology; 1988 Sep; 27(9):949-56. PubMed ID: 2460797
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
17. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
Hu JR; el-Fakahany EE
Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
[TBL] [Abstract][Full Text] [Related]
19. Neuronal and myogenic muscarinic effects of McN-A-343 on guinea pig longitudinal smooth muscle-myenteric plexus.
Ballabeni V; Barocelli E; Chiavarini M; Bordi F; Impicciatore M
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):437-44. PubMed ID: 1282823
[TBL] [Abstract][Full Text] [Related]
20. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
